Volume 4, Issue 1 (September 2018)
Journal of Research in Applied and Basic Medical Sciences 2018, 4(1): 1-5 |
Back to browse issues page
Cellular and Molecular Research Center, Cellular and Molecular Medicine Institute, Urmia University of Medical Sciences, Urmia, Iran. , isaabdirad@yahoo.com
Abstract: (2207 Views)
Background & Aims: Factor XIII controls hemostatic, bleeding and thrombotic state. Inherited Factor XIII deficiency leads to an increased thrombotic tendency. Present study investigates the factor XIII gene Val34Leu mutation in the Iranian Turkish healthy females.
Materials and Methods: Totally 100 unrelated healthy Turkish females entered the study. 3-5 ml whole blood was collected in tube containing EDTA. Salting out method was used for isolation of genomic DNA from blood samples. Dde I based RFLP-PCR was performed to determine the factor XIII gene Val34Leu mutation in tested samples.
Results: Our results showed that frequencies of G (Val) and T (Leu) alleles, and also, G/G (Val/Val), G/T (Val/Leu) and T/T (Leu/Leu) genotypes of factor XIII were 165(84.18%) and 31(15.82%), and also, 67(68.37%), 31(31.63%) and 0(0%) in the tested group. Factor XIII gene Val34Leu genotypes showed an excellent fit to Hardy-Weinberg equilibrium in tested population (χ2 = 3.45 < 3.84, P-value (with degree of freedom=2) =0.177> 0.05). In this study, factor XIII G (Val) and T (Leu) allele frequencies were 0.84 and 0.16, respectively.
Conclusion: Our findings suggested that Factor XIII Val34Leu mutation has a very low prevalence in the tested population. These results from the Iranian Turkish females are the first official report and could be considered as control group for studies relating the prevalence of factor XIII gene Val34Leu mutation with human primary hemostatic, spontaneous bleeding and thrombotic disorders.
Materials and Methods: Totally 100 unrelated healthy Turkish females entered the study. 3-5 ml whole blood was collected in tube containing EDTA. Salting out method was used for isolation of genomic DNA from blood samples. Dde I based RFLP-PCR was performed to determine the factor XIII gene Val34Leu mutation in tested samples.
Results: Our results showed that frequencies of G (Val) and T (Leu) alleles, and also, G/G (Val/Val), G/T (Val/Leu) and T/T (Leu/Leu) genotypes of factor XIII were 165(84.18%) and 31(15.82%), and also, 67(68.37%), 31(31.63%) and 0(0%) in the tested group. Factor XIII gene Val34Leu genotypes showed an excellent fit to Hardy-Weinberg equilibrium in tested population (χ2 = 3.45 < 3.84, P-value (with degree of freedom=2) =0.177> 0.05). In this study, factor XIII G (Val) and T (Leu) allele frequencies were 0.84 and 0.16, respectively.
Conclusion: Our findings suggested that Factor XIII Val34Leu mutation has a very low prevalence in the tested population. These results from the Iranian Turkish females are the first official report and could be considered as control group for studies relating the prevalence of factor XIII gene Val34Leu mutation with human primary hemostatic, spontaneous bleeding and thrombotic disorders.
Type of Study: orginal article |
Subject:
General
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |